SENSUS HEALTHCARE INC (SRTS) Stock Earnings & Estimates
USA - NASDAQ:SRTS - US81728J1097 - Common Stock
3.14 USD
+0.05 (+1.62%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 44.53M 64.68% | 24.405M -45.19% | 41.807M 71.31% | 32.08M -23.27% | 46.881M 46.14% | 60.915M 29.94% | 69.609M 14.27% | 80.05M 15.00% | 92.057M 15.00% | |
| EBITDA YoY % growth | 15.15M 220.30% | 79K -99.48% | 8.522M 10,687.34% | 5.088M -40.30% | 13.277M 160.95% | 19.754M 48.78% | -4.95M -125.06% | -12.146M -145.37% | -21.921M -80.48% | |
| EBIT YoY % growth | 14.83M 259.95% | -382K -102.58% | 8.09M 2,217.80% | -4.036M -149.89% | 4.463M 210.57% | 12.467M 179.34% | 12.487M 0.16% | 14.36M 15.00% | 16.514M 15.00% | |
| Operating Margin | 33.30% | -1.57% | 19.35% | -12.58% | 9.52% | 20.47% | 17.94% | 17.94% | 17.94% | |
| EPS YoY % growth | 0.68 183.33% | 0.03 -95.59% | 0.40 1,233.33% | -0.13 -131.62% | 0.41 424.19% | 0.59 43.03% | 0.60 2.61% | 0.69 15.25% | 0.80 14.71% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 -213.66% | 0.01 -84.13% | 0.01 103.19% | 0.04 159.50% | 0.13 260.26% | 0.23 1,507.14% |
| Revenue Q2Q % growth | 6.379M -27.83% | 9.732M -25.52% | 9.693M 16.17% | 10.922M 49.31% | 10.261M 60.86% | 15.348M 57.71% |
| EBITDA Q2Q % growth | -494.7K -127.59% | 1.022M -52.64% | 1.734M 169.33% | 2.04M 224.39% | 1.428M 388.66% | 3.06M 199.41% |
| EBIT Q2Q % growth | -1.837M -222.88% | -2.856K -100.17% | 251.603K 109.51% | 981.24K 150.50% | 2.667M 245.18% | 4.857M 170,163.03% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.06 -160.00% | 0.03 | -0.09 | -326.24% |
| Q1 2025 Q2Q % growth | -0.16 -214.29% | 0.03 | -0.19 | -561.36% |
| Q4 2024 Q2Q % growth | 0.09 -65.38% | 0.13 | -0.04 | -28.84% |
| Q3 2024 Q2Q % growth | 0.07 177.78% | -0.01 | 0.08 | 786.27% |
| Q2 2024 Q2Q % growth | 0.10 600.00% | 0.02 | 0.08 | 320.23% |
| Q1 2024 Q2Q % growth | 0.14 216.67% | -0.06 | 0.20 | 349.55% |
| Q4 2023 Q2Q % growth | 0.26 52.94% | 0.12 | 0.14 | 108.94% |
| Q3 2023 Q2Q % growth | -0.09 -181.82% | -0.02 | -0.07 | -390.20% |
| Q2 2023 Q2Q % growth | -0.02 -109.52% | -0.08 | 0.06 | 74.20% |
| Q1 2023 Q2Q % growth | -0.12 -163.16% | 0.13 | -0.25 | -191.91% |
| Q4 2022 Q2Q % growth | 0.17 -46.88% | 0.23 | -0.06 | -27.54% |
| Q3 2022 Q2Q % growth | 0.11 1,000.00% | 0.13 | -0.02 | -14.41% |
| Q2 2022 Q2Q % growth | 0.21 1,150.00% | 0.13 | 0.08 | 55.97% |
| Q1 2022 Q2Q % growth | 0.19 371.43% | 0.34 | -0.15 | -43.55% |
| Q4 2021 Q2Q % growth | 0.32 1,500.00% | 0.17 | 0.15 | 91.30% |
| Q3 2021 Q2Q % growth | 0.01 107.14% | -0.02 | 0.03 | 158.81% |
| Q2 2021 Q2Q % growth | -0.02 87.50% | -0.06 | 0.04 | 64.35% |
| Q1 2021 Q2Q % growth | -0.07 68.18% | -0.10 | 0.03 | 30.21% |
| Q4 2020 Q2Q % growth | 0.02 -66.67% | -0.11 | 0.13 | 117.56% |
| Q3 2020 Q2Q % growth | -0.14 -250.00% | -0.14 | 0.00 | -1.67% |
| Q2 2020 Q2Q % growth | -0.16 -1,700.00% | -0.18 | 0.02 | 12.85% |
| Q1 2020 Q2Q % growth | -0.22 -69.23% | -0.07 | -0.15 | -215.65% |
| Q4 2019 Q2Q % growth | 0.06 | 0.03 | 0.03 | 107.64% |
| Q3 2019 Q2Q % growth | -0.04 | -0.03 | -0.01 | -17.66% |
| Q2 2019 Q2Q % growth | 0.01 | -0.05 | 0.06 | 119.06% |
| Q1 2019 Q2Q % growth | -0.13 | -0.03 | -0.10 | -271.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 7.315M -20.82% | 9.487M | -2.172M | -22.89% |
| Q1 2025 Q2Q % growth | 8.344M -21.75% | 7.379M | 965K | 13.08% |
| Q4 2024 Q2Q % growth | 13.067M 3.99% | 11.062M | 2.005M | 18.13% |
| Q3 2024 Q2Q % growth | 8.839M 126.76% | 6.013M | 2.826M | 47.00% |
| Q2 2024 Q2Q % growth | 9.239M 104.09% | 7.142M | 2.097M | 29.36% |
| Q1 2024 Q2Q % growth | 10.663M 212.33% | 4.202M | 6.461M | 153.76% |
| Q4 2023 Q2Q % growth | 12.566M -4.08% | 11.281M | 1.285M | 11.39% |
| Q3 2023 Q2Q % growth | 3.898M -56.74% | 6.002M | -2.104M | -35.05% |
| Q2 2023 Q2Q % growth | 4.527M -62.52% | 4.641M | -114K | -2.46% |
| Q1 2023 Q2Q % growth | 3.414M -66.98% | 10.336M | -6.922M | -66.97% |
| Q4 2022 Q2Q % growth | 13.1M 0.54% | 13.241M | -141K | -1.06% |
| Q3 2022 Q2Q % growth | 9.01M 62.93% | 9.729M | -719K | -7.39% |
| Q2 2022 Q2Q % growth | 12.08M 122.88% | 9.747M | 2.333M | 23.94% |
| Q1 2022 Q2Q % growth | 10.34M 236.81% | 6.867M | 3.473M | 50.58% |
| Q4 2021 Q2Q % growth | 13.03M 155.99% | 11.308M | 1.722M | 15.23% |
| Q3 2021 Q2Q % growth | 5.53M 241.36% | 5.681M | -151K | -2.66% |
| Q2 2021 Q2Q % growth | 5.42M 359.32% | 4.366M | 1.054M | 24.14% |
| Q1 2021 Q2Q % growth | 3.07M 82.74% | 3.767M | -697K | -18.50% |
| Q4 2020 Q2Q % growth | 5.09M -40.19% | 2.578M | 2.512M | 97.44% |
| Q3 2020 Q2Q % growth | 1.62M -72.26% | 2.08M | -460K | -22.12% |
| Q2 2020 Q2Q % growth | 1.18M -84.22% | 1.566M | -386K | -24.65% |
| Q1 2020 Q2Q % growth | 1.68M -69.12% | 5.79M | -4.11M | -70.98% |
| Q4 2019 Q2Q % growth | 8.51M | 8.757M | -247K | -2.82% |
| Q3 2019 Q2Q % growth | 5.84M | 7.584M | -1.744M | -23.00% |
| Q2 2019 Q2Q % growth | 7.48M | 7.483M | -3K | -0.04% |
| Q1 2019 Q2Q % growth | 5.44M | 7.629M | -2.189M | -28.69% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -750% | -360% | -212.73% | -138.04% |
| Revenue | -22.19% | -41.37% | -26.45% | -26.45% |